* Sees FY EPS of $3.70-$3.80
* Shares climb 2 percent (Adds details from results)
NEW YORK, July 21 (Reuters) - Quest Diagnostics Inc (DGX.N), the No. 1 U.S. medical testing provider, posted a 17 percent rise in quarterly profit on Tuesday as the company’s revenue per test requisition increased.
Shares rose 2 percent to $57.15 in premarket trading as the results beat Wall Street estimates.
Net income rose to $188.2 million, or $1.00 per share, compared with $161.3 million, or 82 cents per share, a year earlier.
Excluding charges, earnings per share of $1.04 were 8 cents ahead of analyst estimates, according to Reuters Estimates.
Revenue rose 3.5 percent to $1.9 billion.
Quest boosted its forecast for earnings from continuing operations to a range of $3.70 per share to $3.80 per share. Previously, it had projected $3.65 to $3.75. (Reporting by Lewis Krauskopf; Editing by Derek Caney and Gerald E. McCormick)